Bortega

Bortezomib is a medication used for managing certain conditions, including multiple myeloma and mantle cell lymphoma. It works by targeting proteins in cells to inhibit growth.

Bortezomib is primarily used in the treatment of multiple myeloma and mantle cell lymphoma. It is often administered intravenously or subcutaneously. The medication targets specific proteins in cells to help manage these conditions. Patients and healthcare providers determine the appropriate use based on individual needs.

Common effects of Bortezomib may include fatigue, nausea, and peripheral neuropathy. Some individuals may experience diarrhea or constipation. These effects can vary in severity and duration, depending on the individual.

Bortezomib should be handled with care, following the guidelines provided by healthcare professionals. It is important to store and administer the medication as directed to ensure safety and effectiveness. Patients should discuss any pre-existing conditions or medications with their healthcare provider before use.

Bortezomib may interact with other medications, including those that affect liver enzymes. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain foods may also affect how the body processes Bortezomib.